Pfizer in talks to buy Wyeth for $60 billion: report

NEW YORK/LONDON (Reuters) – Pfizer Inc, the world’s largest drugmaker by revenue, is in talks to acquire rival Wyeth in a deal that could be valued at more than billion, according to the Wall Street Journal.

Comments are closed.